Do you want to read an article? Please log in or register.
Tobacco smoke exposure and socioeconomic factors are independent predictors of pulmonary decline in pediatric cystic fibrosis
Pulmonary Fibrosis
RECOMMENDED
Related content
RECOMMENDED
Pulmonary Fibrosis
Tobacco smoke exposure in pediatric cystic fibrosis: A qualitative study of clinician and caregiver perspectives on smoking cessation
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Pediatr Pulmonol.
Oates GR, Harris WT, Gutierrez HH, Mims C, Rutland SB, Ott C, Niranjan SJ, Scarinci IC, Walley SC
doi: 10.1002/ppul.24879.
RECOMMENDED
Pulmonary Fibrosis
Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis
Cochrane Database Syst Rev.
Smith S, Rowbotham NJ, Charbek E
doi: 10.1002/14651858.
Interstitial Lung DiseasePulmonary Fibrosis
Tobacco smoking and risk for pulmonary fibrosis: A prospective cohort study in UK Biobank
Chest
Bellou V, Belbasis L, Evangelou E
doi: 10.1016/j.chest.2021.04.035
RECOMMENDED
Pulmonary Fibrosis
Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry Cohort study
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Eur Respir J
McKone EF, Ariti C, Jackson A, Zolin A, Carr SB, Orenti A, van Rens J, Lemonnier L, Macek M Jr, Keogh RH, Naehrlich L, European Cystic Fibrosis Society Patient Registry.
doi: 10.1183/13993003.02288-2020
Pulmonary Fibrosis
Impact of a cystic fibrosis transmembrane conductance regulator (CFTR) modulator on high-dose ibuprofen therapy in pediatric cystic fibrosis patients
Pediatr Pulmonol.
Bruch BA, Singh SB, Ramsey LJ, Starner TD
doi: 10.1002/ppul.24024.
Pulmonary Fibrosis
Short-Term Effects of Elastic Chest Wall Restriction on Pulmonary Function in Children with Cystic Fibrosis
Respiration.
Roethlisberger K, Nyilas S, Riedel T, Wolfensberger J, Singer F, Latzin P
doi: 10.1159/000491094.
Effect of smoking and comorbidities on survival in idiopathic pulmonary fibrosis
Respir Res.
Kärkkäinen M, Kettunen HP, Nurmi H, Selander T, Purokivi M, Kaarteenaho R
doi: 10.1186/s12931-017-0642-6.
Lung clearance index to monitor treatment response in pulmonary exacerbations in preschool children with cystic fibrosis
Thorax.
Rayment JH, Stanojevic S, Davis SD, Retsch-Bogart G, Ratjen F
doi: 10.1136/
First experience in Switzerland in Phe508del homozygous cystic fibrosis patients with end-stage pulmonary disease enrolled in a lumacaftor-ivacaftor therapy trial - preliminary results
Swiss Med Wkly.
Murer C, Huber LC, Kurowski T, Hirt A, Robinson CA, Bürgi U, Benden C
doi: 10.4414/smw.2018.14593.